Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Exchange Rate Effect of -$50000.0 for Q2 2026, down 108.4% year-over-year from $595000.0 in Q2 2025, and up 63.77% quarter-over-quarter from -$138000.0 in Q1 2026.
Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$50000.0 for Q2 2026.
- In Q2 2026, Exchange Rate Effect fell 108.4% year-over-year to -$50000.0; the TTM figure through Jun 2026 stood at -$313000.0 (down 145.3% YoY), while the FY2025 annual figure was $702000.0, up 357.14% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at -$50000.0, up from -$138000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $595000.0 in Q2 2025, with the low at -$486000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$46500.0 (2025), against an average of $9722.2.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 1800.0% in 2022, then soared 2686.96% in 2025.
- Ionis Pharmaceuticals' Exchange Rate Effect stood at $546000.0 in 2022, then slumped by 39.56% to $330000.0 in 2023, then sank by 247.27% to -$486000.0 in 2024, then surged by 91.15% to -$43000.0 in 2025, then retreated by 16.28% to -$50000.0 in 2026.
- Business Quant data shows IONS's Exchange Rate Effect at -$50000.0 in Q2 2026, -$138000.0 in Q1 2026, and -$43000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | -50,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50,000.00 |
| Jun 30, 2026 | -50,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Mar 31, 2024 | -114,000.00 |